Viatrexx-Arthros is a Intramuscular; Intravenous; Parenteral; Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Viatrexx Bio Incorporated. The primary component is Anti-interleukin-1.alpha. Immunoglobulin G Rabbit; .alpha.-lipoic Acid; Sus Scrofa Joint Capsule; Bos Taurus Joint Capsule; Sus Scrofa Adrenal Gland; Bos Taurus Adrenal Gland; Beta-endorphin Human; Sus Scrofa Solar Plexus; Bos Taurus Solar Plexus; Sus Scrofa Cartilage; Bos Taurus Cartilage; Pork Collagen; Interleukin-12 Human; Pork Liver; Beef Liver; Sus Scrofa Mesenchyme; Bos Taurus Mesenchyme; Bos Taurus Parathyroid Gland; Sus Scrofa Parathyroid Gland; Quinhydrone; Bos Taurus Vein; Sus Scrofa Vein; .alpha.-ketoglutaric Acid; Apomorphine; Ascorbic Acid; Brain-derived Neurotrophic Factor Human; Basic Fibroblast Growth Factor (human); Calcitonin; Colchicum Autumnale Bulb; Sus Scrofa Red Blood Cell; Bos Taurus Red Blood Cell; Interferon Gamma-1a; Sus Scrofa Lymph Vessel; Bos Taurus Lymph Vessel; Nadide; Sus Scrofa Placenta; Bos Taurus Placenta; Human Placental Tissue; Sulfur.
Product ID | 73069-035_9a52e380-ace6-487b-bb23-f6c2f9644bcc |
NDC | 73069-035 |
Product Type | Human Prescription Drug |
Proprietary Name | Viatrexx-Arthros |
Generic Name | Anti-interleukin 1, Alpha Ketoglutaric Acid, Alpha Lipoic Acid, Apomorphine, Articulation Capsule, Ascorbic Acid, Adrenal, Bdnf, Beta Endorphin, Bfgf, Coelliac Plexus, Calcitonin, Cartilage, Colchicum Automnale, Collagen, Erythrocytes, Interleukin-12, Interferon Gamma, Liver, Lymph Node, Mesenchyme, Nadid, Parathyroid, Placenta, Quinhydrone, Sulphur, Vein |
Dosage Form | Injection |
Route of Administration | INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS |
Marketing Start Date | 2019-03-29 |
Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
Labeler Name | VIATREXX BIO INCORPORATED |
Substance Name | ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT; .ALPHA.-LIPOIC ACID; SUS SCROFA JOINT CAPSULE; BOS TAURUS JOINT CAPSULE; SUS SCROFA ADRENAL GLAND; BOS TAURUS ADRENAL GLAND; BETA-ENDORPHIN HUMAN; SUS SCROFA SOLAR PLEXUS; BOS TAURUS SOLAR PLEXUS; SUS SCROFA CARTILAGE; BOS TAURUS CARTILAGE; PORK COLLAGEN; INTERLEUKIN-12 HUMAN; PORK LIVER; BEEF LIVER; SUS SCROFA MESENCHYME; BOS TAURUS MESENCHYME; BOS TAURUS PARATHYROID GLAND; SUS SCROFA PARATHYROID GLAND; QUINHYDRONE; BOS TAURUS VEIN; SUS SCROFA VEIN; .ALPHA.-KETOGLUTARIC ACID; APOMORPHINE; ASCORBIC ACID; BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN; BASIC FIBROBLAST GROWTH FACTOR (HUMAN); CALCITONIN; COLCHICUM AUTUMNALE BULB; SUS SCROFA RED BLOOD CELL; BOS TAURUS RED BLOOD CELL; INTERFERON GAMMA-1A; SUS SCROFA LYMPH VESSEL; BOS TAURUS LYMPH VESSEL; NADIDE; SUS SCROFA PLACENTA; BOS TAURUS PLACENTA; HUMAN PLACENTAL TISSUE; SULFUR |
Active Ingredient Strength | 201 [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL |
Pharm Classes | Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Meat Proteins [EXT],Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA],Depigmenting Activity [PE],Dopamine Agonists [MoA],Dopaminergic Agonist [EPC],Vitamin C [EPC],Ascorbic Acid [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-05-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-05 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-05 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-05 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-05 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Ingredient | Strength |
---|---|
ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT | 201 [kp_C]/mL |